PressAugust 9, 2021 Ketamine One to Provide Scent-Enabled Virtual Reality Via Exclusive Agreement for Psychedelic Molecules With OVR Technology
PressAugust 6, 2021 COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021
PressAugust 5, 2021 PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease
PressAugust 4, 2021 Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK
PressAugust 3, 2021 MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology
PressJuly 29, 2021 Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
PressJuly 27, 2021 Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
PressJuly 26, 2021 Awakn Life Sciences Commences Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’
PressJuly 23, 2021 Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”
Market ResearchJuly 22, 2021 Contemplating a psychedelic “trip”? Here is all you need to know about two of your options: Psilocybin vs. DMT
PressJuly 21, 2021 Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
PressJuly 20, 2021 Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol “LVT”.
PressJuly 19, 2021 Knowde Group Inc. Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.
